NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research report report published on Thursday morning. The firm issued a sell rating on the medical device company’s stock.

NeuroMetrix Trading Down 2.0 %

NeuroMetrix stock opened at $2.92 on Thursday. The firm has a market capitalization of $5.87 million, a P/E ratio of -0.46 and a beta of 2.30. The stock has a fifty day moving average price of $3.64 and a 200 day moving average price of $3.76. NeuroMetrix has a 52 week low of $2.70 and a 52 week high of $7.19.

NeuroMetrix (NASDAQ:NURO) last released its earnings results on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. The business had revenue of $1.09 million during the quarter. NeuroMetrix had a negative net margin of 151.51% and a negative return on equity of 39.85%.

Institutional Investors Weigh In On NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC purchased a new position in shares of NeuroMetrix, Inc. (NASDAQ:NURO) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix at the end of the most recent reporting period. Institutional investors own 19.40% of the company’s stock.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.